Vanguard Group Inc. Has $290.39 Million Holdings in Patterson Companies, Inc. (NASDAQ:PDCO)

Vanguard Group Inc. grew its stake in shares of Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,409,915 shares of the company's stock after purchasing an additional 47,897 shares during the quarter. Vanguard Group Inc. owned approximately 10.65% of Patterson Companies worth $290,390,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in PDCO. Values First Advisors Inc. increased its position in shares of Patterson Companies by 2.9% during the 4th quarter. Values First Advisors Inc. now owns 11,961 shares of the company's stock valued at $369,000 after purchasing an additional 337 shares during the period. Anchor Investment Management LLC boosted its stake in Patterson Companies by 20.5% during the third quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock valued at $51,000 after buying an additional 400 shares in the last quarter. Blue Trust Inc. grew its holdings in Patterson Companies by 18.0% during the fourth quarter. Blue Trust Inc. now owns 2,738 shares of the company's stock worth $84,000 after acquiring an additional 417 shares during the period. Spire Wealth Management raised its position in Patterson Companies by 11.2% in the fourth quarter. Spire Wealth Management now owns 4,160 shares of the company's stock worth $128,000 after acquiring an additional 419 shares in the last quarter. Finally, US Bancorp DE boosted its position in shares of Patterson Companies by 1.6% during the 4th quarter. US Bancorp DE now owns 32,767 shares of the company's stock valued at $1,011,000 after purchasing an additional 514 shares in the last quarter. 85.43% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently commented on PDCO. Leerink Partners reissued a "market perform" rating and set a $31.35 target price (up from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Robert W. Baird increased their price objective on Patterson Companies from $25.00 to $31.00 and gave the company a "neutral" rating in a research report on Thursday, December 12th. StockNews.com started coverage on Patterson Companies in a report on Friday, April 4th. They issued a "hold" rating on the stock. Leerink Partnrs downgraded Patterson Companies from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 11th. Finally, Morgan Stanley increased their price target on Patterson Companies from $27.00 to $31.35 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Eleven investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $26.57.

Patterson Companies Stock Up 0.5 %

Shares of PDCO traded up $0.16 during trading hours on Wednesday, reaching $31.22. The company's stock had a trading volume of 2,927,872 shares, compared to its average volume of 1,109,719. The company has a 50 day moving average of $31.11 and a two-hundred day moving average of $27.18. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of 18.26, a P/E/G ratio of 2.71 and a beta of 0.73. Patterson Companies, Inc. has a 1-year low of $19.45 and a 1-year high of $31.79.

Patterson Companies Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.